|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - ILa | -.--% |
|
-0.67% | -16.62% |
| 06-16 | Indaptus Therapeutics, Inc. announced that it expects to receive $12 million in funding | CI |
| 06-05 | Indaptus Therapeutics, Inc. Announces Management Resignations | CI |
| Market Cap | 151M 0 131M 122M 112M 211M 14.35B 214M 1.43B 562M 7.17B 565M 553M 23.86B | P/E 2024 |
-0.52x | P/E 2025 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 142M 0 123M 115M 106M 199M 13.54B 202M 1.35B 530M 6.76B 534M 522M 22.51B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun Yi Dai
CEO | Chief Executive Officer | 39 | 2026-03-22 |
Michael Newman
CTO | Chief Tech/Sci/R&D Officer | 70 | 2021-07-31 |
Yu Ding
DFI | Director of Finance/CFO | 51 | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Natan
BRD | Director/Board Member | 73 | 2026-01-07 |
Jerome Jabbour
BRD | Director/Board Member | 52 | 2026-02-25 |
Jun Yi Dai
CHM | Chairman | 39 | 2026-03-17 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -15.02M -0 -13.04M -12.21M -11.17M -21.08M -1.43B -21.36M -143M -56.04M -715M -56.4M -55.18M -2.38B | -20.85M -0 -18.09M -16.94M -15.5M -29.26M -1.99B -29.64M -198M -77.78M -992M -78.28M -76.58M -3.3B |
| Net Debt | -5.7M -0 -4.95M -4.63M -4.24M -8M -543M -8.11M -54.21M -21.28M -271M -21.41M -20.95M -903M | -8.51M -0 -7.38M -6.91M -6.32M -11.94M -810M -12.09M -80.88M -31.74M -405M -31.94M -31.25M -1.35B |
Employees
-
Sector
-
- Stock Market
- Stocks
- INDP Stock
- NTEC Stock
Select your edition
All financial news and data tailored to specific country editions
